MedWatch

Audientes predicts top sales of USD 4m in 2022, plans capital raise

Following February’s Indian market approval, 2022 will be the first year with actual sales for the hearing aid firm Audientes, which is expecting to reach revenues of DKK 23–27m (USD 3.4–4m). A capital raise sometime this year will also help realize a US push, says CEO Steen Thygesen.

Steen Thygesen, CEO of Audientes | Photo: Audientes / PR

Last month, Danish hearing aid firm Audientes received the final market approval in India for its self-fitting hearing aid, dubbed Ven, enabling the company to start selling devices on the biggest global market for its primary target group.

This makes 2022 the first year where Audientes, which was founded in 2014, can book actual revenues, which the company is expecting to reach DKK 23–27m in 2022 (USD 3.4–4m), according to the company’s newly publicized annual report.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs